Sequential Molecular Changes during Multistage Pathogenesis of Small Peripheral Adenocarcinomas of the Lung

This publication has 42 references indexed in Scilit:

• Mucinous Differentiation Correlates with Absence of EGFR Mutation and Presence of KRAS Mutation in Lung Adenocarcinomas with Bronchioloalveolar Features
  The Journal of Molecular Diagnostics, 2007
• Polymorphisms, Mutations, and Amplification of the EGFR Gene in Non-Small Cell Lung Cancers
  PLoS Medicine, 2007
• Lung adenocarcinomas induced in mice by mutant EGF receptors foundin human lung cancers respondto a tyrosine kinase inhibitor orto down-regulation of the receptors
  Genes & Development, 2006
• Epidermal growth factor receptor gene mutation defines distinct subsets among small adenocarcinomas of the lung
  Lung Cancer, 2006
• Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers
  International Journal of Cancer, 2006
• Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
  New England Journal of Medicine, 2005
• KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
  PLoS Medicine, 2005
• EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
  Proceedings of the National Academy of Sciences, 2004
• EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
  Science, 2004
• Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
  New England Journal of Medicine, 2004